BridgeBio Neutral Stance From Citi Shakes ATTR-CM Outlook
Citi initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
This article evaluates which allocation—S&P 500 or Total Market—better supports retirement goals, with actionable insights for allocators.
28,550 articlesCiti initiates BridgeBio at Neutral, signaling caution on ATTR-CM growth despite a strong near-term ramp. The move ad...
Two popular crypto ETFs lure different investors: one sticks to Bitcoin, the other broadens the net. This guide expla...
A disciplined plan using leveraged ETFs can magnify gains in strong markets, but path dependence and decay risk loom....
A powerful rally in spacex stock surged again today, led by a game-changing AI acquisition and strong market momentum...
Bitcoin trades in the mid-$60,000s after a major unwind of leveraged bets. Analysts say institutional demand could st...
The AI hype is undeniable, but investors want answers: is this a bubble about burst just or the start of a longer asc...
After a string of near-misses, Netflix finally makes acquisition that seems to align with its long-term plan. This pi...
Sam Altman is driving OpenAI toward a trillion-dollar target, while SoftBank faces a substantial loan due in 2027. Th...
A major move by hedge fund incline global to liquidate its Maplebear stake prompts a closer look at CART stock. Read ...
Niche energy tech stocks can surge on fresh coverage and bullish notes. This guide explains why the nano nuclear ener...
XSHD's high-yield strategy faces a payout squeeze as distributions shrink while prices slide. The result: a 5%–7% yie...
When headlines shout about a stalled housing bill, borrowers can feel exposed. This article breaks down what the stal...